High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.0M
$5,042,465
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2026-02-06
$145,219
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2026-02-06 | $145,219 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2026-01-20
$535,099x2
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2026-01-20 | $535,099x2 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2026-01-09
$2,482,578Largex2
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2026-01-09 | $2,482,578Largex2 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2026-01-08
$993,436x2
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2026-01-08 | $993,436x2 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2025-12-19
$84,206
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2025-12-19 | $84,206 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2025-11-19
$279,155x2
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2025-11-19 | $279,155x2 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2025-10-20
$276,025
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2025-10-20 | $276,025 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2025-09-26
$81,005
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2025-09-26 | $81,005 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2025-09-23
$30,045
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2025-09-23 | $30,045 | S | Form 4 |
|
ELVN
S
Enliven Therapeutics, Inc.
Lyssikatos Joseph P
• Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
2025-09-19
$135,697x2
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Officer • CHIEF SCIENTIFIC OFFICER
10b5-1 Sell
|
2025-09-19 | $135,697x2 | S | Form 4 |